Superdisintegrants Market Size Worth $ 829.54 Million By 2032 | CAGR: 7.3%

Superdisintegrants Market Size Worth $ 829.54 Million By 2032 | CAGR: 7.3%

The global superdisintegrants market size is expected to reach USD 829.54 million by 2032, according to a new study by Polaris Market Research. The report “Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2024-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer has increased the demand for drugs. Superdisintegrants play a vital role in formulating these drugs, making them essential components in the pharmaceutical industry. The most non-communicable disease deaths (NCD), 17.9 million per year, are caused by cardiovascular diseases, followed by cancer (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (1.2 million) (2.0 million, including fatalities from renal disease brought on by diabetes)). This will drive the growth of the market in the upcoming years.

 Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

Advancements in technology have led to the development of new and more efficient super disintegrants. For instance, recent studies have investigated using banana powder as a super disintegrant in various pharmaceutical formulations, including tablets and capsules. This has led to increased use of these excipients in formulating multiple drugs. The demand for generic drugs is rising due to their affordability and accessibility.

The increasing use of super disintegrants in the pharmaceutical industry, coupled with the growing number of patents being filed for new and innovative solutions, is driving the growth of the super disintegrants market. According to the combination of data from the National Institute of Standards & Technology (NIST) and the United Nations Patent and Trademark Office (USPTO), N-Vinyl pyrrolidone+sodium starch glycolate has 15 patents, followed by Amylose with 14 patents. This trend is expected to continue in the coming years as drug manufacturers seek to develop more efficient and effective drug delivery systems.

Superdisintegrants Market Report Highlights

  • Crospovidone segment is anticipated to grow due to increasing demand for fast dissolving dosage forms.
  • Tablets segment is registered the highest growth rate owing to the as tablets are the most used dosage form in the pharmaceutical industry and superdisintegrants are critical ingredients in tablet formulations.
  • Gastrointestinal diseases are projected to experience significant growth rate due to the growing incidence of GI disorders and increased focus on patient-centric drug delivery.
  • North America is expected to have the largest revenue share owing to the strong increasing incidence of chronic diseases and technological advancements.
  • APAC is projected to witness significant growth rate in the coming years due to the growing pharmaceutical industry in developing countries like China and India.
  • The global players include BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma & Avantor Performance.

Polaris Market Research has segmented the superdisintegrants market report based on product, formulation, therapeutic area, and region:

Superdisintegrants, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Modified Starch
  • Modified Cellulose
  • Crospovidone
  • Ion Exchange Resin

Superdisintegrants, Formulation Outlook (Revenue - USD Million, 2019 - 2032)

  • Tablets
  • Capsules

Superdisintegrants, Therapeutic area Outlook (Revenue - USD Million, 2019 - 2032)

  • Gastrointestinal Diseases
  • Neurological Diseases
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological Diseases
  • Inflammatory Diseases

Superdisintegrants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
    • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Superdisintegrants Market Report Scope

Report Attributes


Market size value in 2024

USD 470.7 million

Revenue forecast in 2032

USD 829.54 million


7.3% from 2024 - 2032

Base year


Historical data

2019 - 2022

Forecast period

2024 - 2032

Quantitative units

Revenue in USD million/billion and CAGR from 2024 to 2032

Segments covered

By Product, By Formulation, By Therapeutic Area, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma Chem & Avantor Performance.

For Specific Research Requirements

Request for Customized Report